West Pharmaceutical Services holds the cleaner structural position, with the lead spread across growth and profitability. bioMérieux still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels.
This is not just a one-metric split: both growth and profitability materially support the lead. The overall score gap is 21 points in favour of West Pharmaceutical Services, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.
Most of the shared profile comes through revenue stability and capital structure.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Neither company combines the stronger profile with the cheaper valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
One company is still expanding while the other is contracting, which creates a very wide growth split.
Stability still leans toward bioMérieux S.A., so the lead is real without reading as one-way.
The lead is built on both growth and profitability — though stability still provides a counterweight.
Break down the BIM.PA vs WST comparison across all dimensions with the full interactive tool.
Explore how BIM.PA and WST each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.